Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.

Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.

Virus-specific CD4+ T cells with IL-2-secreting and/or proliferative capacity are detected readily in HIV-1-infected long-term nonprogressors and rarely in persons with untreated progressive infection. The contribution of these cells to viraemia control is uncertain, but this question might be addre...

書目詳細資料
Main Authors:	Ondondo, B, Yang, H, Dong, T, di Gleria, K, Suttill, A, Conlon, C, Brown, D, Williams, P, Rowland-Jones, S, Hanke, T, Mcmichael, A, Dorrell, L
格式:	Journal article
語言:	English
出版:	2006

相似書籍

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.
由: Dorrell, L, et al.
出版: (2006)

Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
由: Dorrell, L, et al.
出版: (2007)

Detection of broad functional gag-specific CD4+T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
由: Ondondo, B, et al.
出版: (2006)

Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
由: Rowland-Jones Sarah L, et al.
出版: (2006-12-01)

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.
由: Dorrell, L, et al.
出版: (2005)

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
由: Nixon, D, et al.
出版: (1988)

pTHr.HIVA and MVA.HIVA vaccines (gag p24/p17) augment CD4+T cell responses in chronically infected HIV-1 patients on HAART
由: Ondondo, B, et al.
出版: (2005)

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.
由: Mwau, M, et al.
出版: (2004)

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects.
由: Howles, S, et al.
出版: (2010)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
由: Dorrell, L, et al.
出版: (2000)

Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.
由: Slyker, J, et al.
出版: (2005)

Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia.
由: Ondondo, B, et al.
出版: (2008)

Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy.
由: Yang, H, et al.
出版: (2007)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
由: Hanke, T, et al.
出版: (2007)

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes.
由: Goonetilleke, N, et al.
出版: (2006)

Erratum: Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction (Journal of General Virology (2007) vol. 88 ( 1) (1-12))
由: Hanke, T, et al.
出版: (2008)

Targeting HIV-1 where it hurts
由: Borthwick, N, et al.
出版: (2013)

Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay.
由: Winstone, N, et al.
出版: (2009)

Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART.
由: Sutherland, R, et al.
出版: (2006)

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers.
由: Cebere, I, et al.
出版: (2006)

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
由: Bauer A, et al.
出版: (2012-09-01)

Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya.
由: Hanke, T, et al.
出版: (2002)

Cardiac Safety in Clinical Trials with Preventive HIV Vaccine Candidates Based on Modified Vaccinia Ankara (MVA)
由: Schmidt, C, et al.
出版: (2008)

Targeting HIV-1 Where It Hurts
由: Ahmed, T, et al.
出版: (2013)

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate.
由: Jeffrey R Currier, et al.
出版: (2010-11-01)

HIV-gag-specific cytotoxic T lymphocytes.
由: Nixon, D, et al.
出版: (1989)

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.
由: Rolland, M, et al.
出版: (2008)

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.
由: Morgane Rolland, et al.
出版: (2008-01-01)

HIV-1 subtype A gag variability and epitope evolution
由: Abidi, S, et al.
出版: (2014)

Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.
由: Maria L Knudsen, et al.
出版: (2015-01-01)

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
由: Fitzgerald, J, et al.
出版: (2003)

Four novel cytotoxic T-lymphocyte epitopes in the highly conserved major homology region of HIV-1 Gag, restricted through B*4402, B*1801, A*2601, B*70 (B*1509)
由: Ogg, G, et al.
出版: (1998)

Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
由: Sharpe, S, et al.
出版: (2003)

Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
由: Caroline Staib, et al.
出版: (2003-04-01)

HIV-1 subtype A gag variability and epitope evolution.
由: Syed Hani Abidi, et al.
出版: (2014-01-01)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
由: Ahmed, T, et al.
出版: (2012)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
由: Ahmed T, et al.
出版: (2012-09-01)

Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein
由: Nangola Sawitree, et al.
出版: (2012-02-01)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
由: Rosario, M, et al.
出版: (2010)

OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro
由: Barré-Sinoussi F, et al.
出版: (2009-10-01)